PROM1 and pancreatic neoplasm: With regard to this, Hermann et al. have conducted that human CD133+ pancreatic CSCs isolated from pancreatic tumor are highly resistant to standard gemcitabine therapy, which is conventional chemotherapeutic agent against PC [14].